A Novel Facile and Efficient Prophylaxis Avenue of Chitosan Oligosaccharide/PLGA Based Polydatin Loaded Nanoparticles Against Bleomycin-Induced Lung Inflammation in Experimental Rat Model
AAPS PharmSciTech · 16.01.2025 · 26 (1)
DOI: 10.1208/s12249-024-03022-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift AAPS PharmSciTech, online erschienen am 16.01.2025. Verfasst von Ahmed Nashaat Alnagar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Dakahlia, Egypt. Hauptthemen laut MEDLINE: Chitosan, Glucosides, Nanoparticles, Stilbenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mansoura University.
Abstract (Originalsprache)
Lung inflammation is a hallmark of several respiratory diseases. Despite the great effectiveness of the synthetic antiinflammatory agents, they cause potential side effects. Polydatin (PD), a natural phytomedicine, has antioxidant and antiinflammatory effects. Its clinical applications are hindered due to poor aqueous solubility, low bioavailability, and rapid metabolism by first-pass effect. Herein, we report the development of a novel chitosan oligosaccharide-coated PD-loaded Poly dl-lactide-co-glycolide nanoparticles (COS-coated PD/PLGA NPs) against a bleomycin-induced pulmonary inflammation in a rat model. The NPs exhibited a small particle size of 188.57 ± 5.68 nm and a high zeta potential of + 18.13 ± 2.75 mV with spherical architecture and sustained release pattern of PD. In vivo studies in bleomycin-induced lung inflammation in a rat model revealed the superior prophylactic activity of COS-coated PD/PLGA NPs over the free drug (PD) as demonstrated by histopathological and immunohistochemical analyses, alongside biochemical assays evaluating oxidative stress biomarkers and inflammatory cytokine levels. Overall, the optimized COS-coated PD/PLGA NPs formulation offers a promising prophylactic platform against many respiratory diseases. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Dakahlia, Egypt.
- Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Dakahlia, Egypt. a_metawea@mans.edu.eg.
- Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Dakahlia, Egypt.
- Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, 13713, DiriyahRiyadh, Saudi Arabia.
- Department of Human Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Förderung
- Mansoura University
Zitieren
APA
Alnagar, A. N., Motawea, A., Zaghloul, R. A., Eldesoqui, M., & Abu Hashim, I. I. (2025). A Novel Facile and Efficient Prophylaxis Avenue of Chitosan Oligosaccharide/PLGA Based Polydatin Loaded Nanoparticles Against Bleomycin-Induced Lung Inflammation in Experimental Rat Model. AAPS PharmSciTech, 26(1). https://doi.org/10.1208/s12249-024-03022-2
Vancouver
Alnagar AN, Motawea A, Zaghloul RA, Eldesoqui M, Abu Hashim II. A Novel Facile and Efficient Prophylaxis Avenue of Chitosan Oligosaccharide/PLGA Based Polydatin Loaded Nanoparticles Against Bleomycin-Induced Lung Inflammation in Experimental Rat Model. AAPS PharmSciTech. 2025;26(1). doi:10.1208/s12249-024-03022-2
BibTeX
@article{Alnagar2025,
author = {Alnagar, Ahmed Nashaat and Motawea, Amira and Zaghloul, Randa A and Eldesoqui, Mamdouh and Abu Hashim, Irhan Ibrahim},
title = {A Novel Facile and Efficient Prophylaxis Avenue of Chitosan Oligosaccharide/PLGA Based Polydatin Loaded Nanoparticles Against Bleomycin-Induced Lung Inflammation in Experimental Rat Model},
journal = {AAPS PharmSciTech},
year = {2025},
volume = {26},
number = {1},
doi = {10.1208/s12249-024-03022-2}
}
EUVIMED